Xavier Pivot
- Oncology top 0.1%
- HER2/EGFR in Cancer Research 147
- Cancer Treatment and Pharmacology 127
- Colorectal Cancer Treatments and Studies 34
- Global Cancer Incidence and Screening 22
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies 91
- Pulmonary and Respiratory Medicine top 0.2%
- Advanced Breast Cancer Therapies 60
- Genetics top 1%
- Otorhinolaryngology top 1%
-
- Monoclonal and Polyclonal Antibodies Research 49
-
- Biosimilars and Bioanalytical Methods 22
Xavier Pivot
368 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Oncology 8.7k
- Cancer Research 2.9k
- Pulmonary and Respiratory Medicine 4.2k
- Genetics 882
- Otorhinolaryngology 338
Countries citing papers authored by Xavier Pivot
This map shows the geographic impact of Xavier Pivot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Pivot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Pivot more than expected).
Fields of papers citing papers by Xavier Pivot
This network shows the impact of papers produced by Xavier Pivot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Pivot. The network helps show where Xavier Pivot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xavier Pivot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 8 | |
| 8 | 2020 | 27 | |
| 9 | 2018 | 23 | |
| 10 | 2016 | 1 | |
| 11 | 2015 | 49 | |
| 12 | 2014 | 18 | |
| 13 | 2014 | 35 | |
| 14 | 2012 | 76 | |
| 15 | 2011 | 94 | |
| 16 | 2010 | 11 | |
| 17 | 2007 | 32 | |
| 18 | Is there still a role for triple endoscopy as part of staging for head and neck cancer | 2006 | 21 |
| 19 | 2002 | 14 | |
| 20 | Les cancers du larynx et de l'hypopharynx : anatomie, anatomopathologie, signes cliniques, TNM, thérapeutique | 2000 | 1 |
About Xavier Pivot
Xavier Pivot is a scholar working on Oncology, Cancer Research and Otorhinolaryngology, having authored 375 papers that have together received 11.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (147 papers), Cancer Treatment and Pharmacology (127 papers), Breast Cancer Treatment Studies (91 papers), Advanced Breast Cancer Therapies (60 papers), Monoclonal and Polyclonal Antibodies Research (49 papers), Colorectal Cancer Treatments and Studies (34 papers), Global Cancer Incidence and Screening (22 papers) and Biosimilars and Bioanalytical Methods (22 papers). The work is most often cited by research in Oncology (8.7k citations), Cancer Research (2.9k citations) and Pulmonary and Respiratory Medicine (4.2k citations). Xavier Pivot has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Gilles Romieu, Joohyuk Sohn, Antonio Llombart‐Cussac, Masakazu Toi, Javier Cortés, Arlene Chan, Patrick Neven, Han Koh, Peter A. Kaufman and Norikazu Masuda. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, European Journal of Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.